These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32126319)

  • 21. Statins: the new aspirin?
    Veillard NR; Mach F
    Cell Mol Life Sci; 2002 Nov; 59(11):1771-86. PubMed ID: 12530513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
    Sawada N; Liao JK
    Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
    Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
    Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory T cells: Possible mediators for the anti-inflammatory action of statins.
    Shahbaz SK; Sadeghi M; Koushki K; Penson PE; Sahebkar A
    Pharmacol Res; 2019 Nov; 149():104469. PubMed ID: 31577918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and other agents for vascular inflammation.
    Owens CD
    J Vasc Surg; 2012 Dec; 56(6):1799-806. PubMed ID: 23017371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and the development of atherosclerosis.
    Mizuno Y; Jacob RF; Mason RP
    J Atheroscler Thromb; 2011; 18(5):351-8. PubMed ID: 21427505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacogenetics and anti-inflammatory effect of HMG-CoA reductase inhibitors].
    Rosendo AB; Dal-Pizzol F; Fiegenbaum M; Almeida Sd
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):520-5. PubMed ID: 17684611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of statins on endothelial dysfunction and vascular stiffness.
    Dilaveris P; Giannopoulos G; Riga M; Synetos A; Stefanadis C
    Curr Vasc Pharmacol; 2007 Jul; 5(3):227-37. PubMed ID: 17627566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease.
    Sadowitz B; Maier KG; Gahtan V
    Vasc Endovascular Surg; 2010 May; 44(4):241-51. PubMed ID: 20403949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effect of Statins through Mast Cells in the Pathophysiology of Atherosclerosis: a Review.
    Kouhpeikar H; Delbari Z; Sathyapalan T; Simental-Mendía LE; Jamialahmadi T; Sahebkar A
    Curr Atheroscler Rep; 2020 May; 22(5):19. PubMed ID: 32458165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherosclerosis and inflammation: overview and updates.
    Geovanini GR; Libby P
    Clin Sci (Lond); 2018 Jun; 132(12):1243-1252. PubMed ID: 29930142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?
    Meroni PL; Luzzana C; Ventura D
    Clin Rev Allergy Immunol; 2002 Dec; 23(3):263-77. PubMed ID: 12402412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microcirculation as a target for the anti-inflammatory properties of statins.
    Scalia R; Stalker TJ
    Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and Inflammation.
    Satny M; Hubacek JA; Vrablik M
    Curr Atheroscler Rep; 2021 Dec; 23(12):80. PubMed ID: 34851454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials.
    Faraj R; Paine D; Black SM; Wang T
    Adv Exp Med Biol; 2021; 1303():33-56. PubMed ID: 33788186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins and biomarkers of inflammation.
    Devaraj S; Rogers J; Jialal I
    Curr Atheroscler Rep; 2007 Jan; 9(1):33-41. PubMed ID: 17169243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance.
    Biasucci LM; Biasillo G; Stefanelli A
    Clin Chem Lab Med; 2010 Dec; 48(12):1685-91. PubMed ID: 20868311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis: can statins play a dual role?
    Rajpara AN; Goldner R; Gaspari A
    Dermatol Online J; 2010 Feb; 16(2):2. PubMed ID: 20178698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.